Nes­tle Inks $1.4-b Skin­care Deal with Valeant Pharma

The Economic Times - - Companies -

Nes­tle SA, the world’s big­gest food com­pany, said it will ex­pand its skin­care unit in North Amer­ica by pay­ing $1.4 bil­lion in cash for commercial rights to sell some Valeant Phar­ma­ceu­ti­cals prod­ucts. The pur­chase in­cludes cor­rec­tive fa­cial aes­thetic treat­ments Resty­lane, Per­lane and Emervel in the US and Canada.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.